Table 2

Adverse events occurring during the study treatment follow-up

n
Neutropenic fever7
Alopecia, gastric tract symptoms5
Alopecia, fever3
Fever, bone marrow suppression2
Allergic reaction to ATG2
Patient died due to sepsis and DIC1
Staphylococcus haemolyticus bacteremia1
Nausea, fever, rash due to ATG1
Neutropenic fever, mucositis, coagulopathy1
Transient upper right limb edema during conditioning (no signs of thrombosis)1
Pneumothorax after CVC insertion1
Skin rash, neutropenic fever1
Gastric tract symptoms, fever1
Alopecia, fever, failure of stem cell harvest1
Pseudomonas aeruginosa sepsis1
Alopecia, gastric tract symptoms, nutrition support1
Alopecia, fever, hematuria1
Gastric tract symptoms, fever, bone marrow suppression1
Gastric tract symptoms, granulocyte suppression1
Diarrhea1
Total number of subjects experiencing adverse effects34/65
  • ATG, antithymocyte globulin; CVC, central venous catheter; DIC, disseminated intravascular coagulation.